Myers C L, Weiss S J, Kirsh M M, Shlafer M
J Mol Cell Cardiol. 1985 Jul;17(7):675-84. doi: 10.1016/s0022-2828(85)80067-5.
The objective of this study was to test the hypothesis that cytotoxic oxygen metabolites participate in lytic cardiac cell damage, detected as creatine kinase release, upon reoxygenation of hypoxic, isolated buffer-perfused hearts (oxygen paradox). Perfusate additives included: superoxide dismutase (30 mg/l); catalase (2 mg/l); deferoxamine (0.5 mM); and allopurinol (1 mM). Creatine kinase release upon reoxygenation was reduced, to levels not significantly different from nonhypoxic controls, by adding either catalase, allopurinol or deferoxamine to the buffer during hypoxia. Reduced creatine kinase leakage was not accompanied by parallel preservation of ventricular function or coronary vascular resistance. Administration of catalase during hypoxia was superior to administering it only during reoxygenation. Treatment with catalase during both hypoxia and reoxygenation provided no more protection than administration only during hypoxia. The data suggest that an important component of hypoxia-induced cardiac cell damage is due primarily to hydrogen peroxide, which may then form hydroxyl radical. Superoxide anion plays an important role as a precursor of these species, but added superoxide dismutase alone did not significantly reduce creatine kinase loss. The data also suggest that damage resulting in creatine kinase release upon reoxygenation occurs during oxygen deprivation, and it is mediated in part by cytotoxic oxygen metabolites.
在缺氧的离体缓冲液灌注心脏复氧时(氧反常),细胞毒性氧代谢产物参与了以肌酸激酶释放检测到的溶解性心肌细胞损伤。灌注液添加剂包括:超氧化物歧化酶(30毫克/升);过氧化氢酶(2毫克/升);去铁胺(0.5毫摩尔);以及别嘌呤醇(1毫摩尔)。在缺氧期间向缓冲液中添加过氧化氢酶、别嘌呤醇或去铁胺,可使复氧时的肌酸激酶释放减少至与非缺氧对照组无显著差异的水平。肌酸激酶泄漏减少并未伴随心室功能或冠状动脉血管阻力的平行保留。在缺氧期间给予过氧化氢酶优于仅在复氧期间给予。在缺氧和复氧期间均用过氧化氢酶治疗提供的保护并不比仅在缺氧期间给药更多。数据表明,缺氧诱导的心肌细胞损伤的一个重要成分主要归因于过氧化氢,其随后可能形成羟基自由基。超氧阴离子作为这些物质的前体发挥重要作用,但单独添加超氧化物歧化酶并未显著降低肌酸激酶的损失。数据还表明,复氧时导致肌酸激酶释放的损伤发生在缺氧期间,并且部分由细胞毒性氧代谢产物介导。